Alternatives to Informed Sport for Banned Substance Testing

Supplement brands and compliance teams frequently encounter complex decisions regarding third-party banned substance testing. Informed Sport holds widespread recognition and acceptance, but it represents one of several viable options. Its suitability varies based on each organization's risk tolerance and regulatory framework. Independent supplement testing programs differ considerably in scope, testing methodology, and transparency, which directly influences the level of protection provided to athletes and brands in the event of a positive drug test.

Published evaluations demonstrate that 35% of 200 sports supplement products in a single survey contained substances prohibited by WADA. The prevalence of undisclosed substances underscores the importance of selecting an appropriate certification program. This post documents the structure and boundaries of Informed Sport, and summarizes alternative certification models for brands and compliance professionals.

Informed Sport for Banned Substance Testing

Informed Sport is a global third-party certification program administered by LGC in the UK. It applies batch testing to every certified product, targeting over 285 substances on the WADA Prohibited List prior to market release. Certified products appear in a public database, facilitating verification by athletes and organizations. The program is recognized by UK Anti-Doping and employs ISO/IEC 17025-accredited laboratory techniques.

Key Considerations with Informed Sport for Banned Substance Testing

Informed Sport is referenced by organizations including UK Anti-Doping, the UFC, the International Testing Agency, the U.S. Department of Defense's Operation Supplement Safety (OPSS), the LPGA, and CrossFit. Geographic and institutional recognition provides an established baseline for many supplement brands in international distribution.

The current testing panel includes over 285 WADA-listed substances with detection limits at low to mid parts per billion, using ISO/IEC 17025-accredited procedures. Each product batch undergoes testing prior to release, and additional blind sampling audits contribute to overall process control between laboratory testing and retail distribution.

Documented limitations include a testing panel smaller than those of some other programs. Emerging designer substances or newly added compounds may not be screened immediately. The standard program structure involves an initial review of GMP and quality control processes but does not extend to ongoing label validation or contaminant surveillance.

Testing scope differs among providers. A panel of 285 substances does not encompass all possible banned compounds, and organizations subject to strict anti-doping protocols may require broader coverage.

Essential Elements of an Effective Banned Substance Testing Program

Credible banned substance testing programs consistently demonstrate a comprehensive substance panel. Panel sizes currently range from approximately 150 to over 450 compounds, directly affecting the scope of protection offered. Providers should disclose their testing menus publicly for proper assessment.

Alignment with the WADA Prohibited List serves as a global standard. However, sports organizations such as the NFL, MLB, and NCAA include additional substances beyond WADA coverage, which can present further compliance requirements.

Testing frequency indicates the reliability of certification. Lot-based testing offers direct protection for end users. Verification by lot number through a public database provides a practical layer of oversight for athletes and compliance teams.

Laboratory accreditation to ISO/IEC 17025 is generally required. Analytical detection should reach low parts per billion to reduce risk. Programs that allow higher thresholds for performance-enhancing compounds introduce limitations. Transparency in reporting, including public access to the banned substance testing menu and detection limits, differentiates certification providers.

BSCG Approach to Banned Substance Testing Requirements

BSCG (Banned Substances Control Group), established in 2004, leverages expertise in Olympic-level anti-doping sciences and applies that standard to commercial product testing. Co-founder Don H. Catlin, M.D., is recognized for creating and directing the largest sport drug testing laboratory in the world, the UCLA Olympic Analytical Laboratory, for 25 years and contributing to both WADA and USADA founding. Details on BSCG's scientific leadership are available on the BSCG leadership page.

The BSCG Certified Drug Free program performs testing on every finished product lot for over 450 substances. This includes more than 400 WADA-listed compounds and more than 50 prescription, over-the-counter, or illicit drugs not banned in sport—examples include PDE-5 inhibitors, muscle relaxants, benzodiazepines, and weight-loss agents. Other leading competitors cover less than 300 substances in a standard panel.

This program integrates banned substance testing with GMP compliance audits and annual verification of quality control testing for label claims and environmental contaminants. Analyses are conducted in ISO 17025-accredited laboratories using methods specifically validated for supplement products, with detection sensitivity typically in the low parts per billion. BSCG also outlines reporting thresholds publicly without applying maximum per-serving thresholds for performance-enhancers a practice employed by NSF, as detailed in its transparency framework.

Comparative Distinctions: BSCG and Informed Sport

Both BSCG and Informed Sport require batch testing of every finished lot, providing consistent protection to brands and athletes above discretionary sampling or annual models. This shared feature increases product assurance prior to retail distribution.

The primary distinction lies in breadth of the testing panel. Informed Sport covers over 285 WADA-listed substances. BSCG Certified Drug Free screens for over 450 substances, encompassing additional categories outside the WADA list. BSCG documents that more than 400 WADA-prohibited substances on its panel account for over 96% of adverse findings reported by WADA-accredited laboratories since 2006, as referenced on the BSCG drug testing menu page.

Regarding quality integration, Informed Sport includes a one-time GMP and quality assessment. BSCG Certified Drug Free encompasses ongoing banned substance testing, a requirement to maintain GMP certification from a reputable provider, and annual product verification of product specifications and quality control testing.

BSCG discloses its full banned substance testing menu, outlines detection limits and reporting criteria publicly. Informed Sport meets recognized accreditation and disclosure standards but does not publish its testing menu publicly.

Both programs receive recognition from numerous anti-doping and sport governing bodies, with the BSCG global recognition page referencing acknowledgment by the NFL, International Testing Agency, Canadian Centre for Ethics in Sport, Operation Supplement Safety (OPSS), UFC, LPGA, CrossFit and others.

BSCG also offers an all inclusive testing process. This means that initial product screening and confirmation and quantitation of any banned substances detected is done in 10-15 business days for one price. Informed Sport requires additional testing and cost to verify any initial findings, which can add significant time and expense to the testing process if a drug is detected.

Other Reputable Third-Party Certification Providers

Multiple third-party certification bodies operate with established reputations in banned substance testing. The inclusion of these programs below provides context for informed comparisons:

• Informed Choice is a related program managed by LGC. It uses monthly blind sampling strategies instead of pre-release batch testing. It addresses the needs of general supplement users rather than competitive athletes.
• NSF Certified for Sport® tests for approximately 290 substances including stimulants, steroids, diuretics, beta-2 agonists, and masking agents. Manufacturers must hold NSF GMP certification and participate in the NSF Contents Certified program for label and contaminant control. Testing frequency is brand- and product-dependent. The program is referenced by USADA, MLB, the NHL, the Canadian Football League and others.
• HASTA™ (Human and Supplement Testing Australia) screens for over 250 WADA-prohibited substances and requires batch testing for each product lot. The program is recognized by the Australian Institute of Sport, the International Testing Agency, and the UFC.
• Cologne List® (Kölner Liste) primarily targets steroids and stimulants, with annual testing of approximately 150 substances. It functions as a product listing service rather than a full certification model and does not include a GMP audit component.

Further details and side-by-side comparisons are accessible on the BSCG third-party certification comparison page.

Evaluation Criteria for Leadership Teams

Quality assurance and compliance teams should initially compare scope and transparency of banned substance panels. The extent and public disclosure of the banned substance list directly affect the assurance a program delivers. Restricted or undisclosed test menus do not communicate the scope of protection to athletes or consumers.

Testing frequency remains a fundamental consideration. Testing every lot aligns risk mitigation directly with the products reaching end users, whereas monthly or annual sampling provides less detailed assurance. Lot-based verification in public databases enhances traceability and accountability.

Laboratory accreditation and the validation of analytical methods reinforce defensibility and reproducibility of test results. Use of ISO/IEC 17025-accredited labs and matrix-specific validation procedures meets industry expectations.

Program choice should reflect organizational risk profile. Companies serving elite athletes, military personnel, or other regulated populations need to match external requirements with their certification approach. Consistent frequency of testing is essential.

Integration of GMP compliance and label verification within the banned substance testing program reduces administrative burdens and strengthens the overall quality infrastructure. A more inclusive process strengthens compliance protection for brands and quality assurance for consumers.

Supplement Safety: Ongoing Considerations

No certification program can guarantee the complete exclusion of banned substances. International supplement education resources state that rigorous testing substantially reduces but does not eliminate the risk of contamination. Under strict liability rules in sports, athletes remain responsible for any banned substance found in sport drug testing.

Certification providers supply systematic, documented risk reduction methods. The value delivered correlates directly with the banned substance panel size, testing frequency, laboratory rigor, and commitment to transparency. For brand owners, adherence to these standards supports long-term regulatory credibility and market trust.

Certification should be approached as an ongoing quality partnership, not as a one-time procedural step. Continuous alignment with regulatory updates, such as annual WADA Prohibited List changes, and vigilance for emerging compounds remain critical.

Frequently Asked Questions

Are banned substance lists standardized globally?

Banned substance lists generally cover similar substances but with some variation particularly in professional sport where lists are often collectively bargained. The WADA Prohibited List is commonly referenced on an international basis, but organizations such as the NFL, MLB, and NCAA have slightly different list than what WADA covers. Certification alignment with these lists depends on the program structure.

What is the update frequency for providers' prohibited substance lists?

WADA updates its Prohibited List every year, effective January 1. Certification providers update their panels on varying cycles, and integration of new designer compounds may not occur at the same rate. BSCG has continued to expand the coverage offered, which now spans more than 450 drugs, while other providers have not expanded their testing menus as often.

Do certification programs combine banned substance screening with label verification?

Integrated programs exist. For example, BSCG Certified Drug Free and NSF Certified for Sport combine banned substance testing, label claims verification, and GMP compliance within a unified structure. However, integration levels and process frequency vary across providers. BSCG offers a network friendly model, allowing for other reputable testing providers or auditors to fulfill GMP and ongoing quality control testing requirements, while NSF mandates that they handle every component.

Are there differences in test result timelines among certification programs?

Differences primarily relate to the type and timing of testing employed. Batch-by-batch models, such as those used by BSCG Certified Drug Free, Informed Sport, and HASTA, incorporate laboratory review into the production process, while periodic sampling models apply after-market release.

Is there banned substance certification for both human and animal supplements?

BSCG Certified Drug Free offers an equine and canine supplement testing panel focused on banned substances relevant to the racing industry. Other certification programs do not currently include banned substance screening for drugs banned in equine or other animal racing.